Filter
5694
Filtered Results: 5694
Text search:
Centers
for
Disease
Control
and
Prevention
,
World
Health
Organization
WHO
Featured
Recommendations
598
New Publications
1545
Language
Document type
No document type
3162
Studies & Reports
922
Guidelines
786
Manuals
301
Strategic & Response Plan
237
Fact sheets
115
Training Material
69
Situation Updates
58
Resource Platforms
16
Infographics
10
Brochures
8
Online Courses
6
Dashboards/Maps
2
App
2
Countries / Regions
India
246
Global
239
Kenya
168
Sierra Leone
152
Liberia
145
Ethiopia
128
Nigeria
127
Western and Central Europe
122
Uganda
106
Africa
103
South Africa
91
Latin America and the Carribbean
91
Nepal
86
Zambia
83
Malawi
78
Tanzania
76
Rwanda
74
Ukraine
63
Bangladesh
61
Ghana
59
Philippines
58
Syria
56
Myanmar / Burma
56
Congo, Democratic Republic of
55
Eastern Europe
51
Guinea
50
Namibia
50
Mozambique
49
Russia
48
West and Central Africa
47
Middle East and North Africa
46
South Sudan
42
South–East Asia Region
42
Zimbabwe
40
East and Southern Africa
39
Cambodia
38
Asia
37
Senegal
36
Lesotho
32
Haiti
29
Brazil
28
Yemen
28
Germany
27
Indonesia
27
Burkina Faso
26
Eastern Europe and Central Asia
24
Botswana
21
Madagascar
19
Eswatini/ Swaziland
17
Pakistan
16
Colombia
16
Mali
15
Venezuela
15
Cameroon
14
Afghanistan
14
Thailand
14
Western Pacific Region
14
Somalia
13
Sudan
13
Central African Republic
12
Côte d’Ivoire / Ivory Coast
11
Angola
11
Moldova
11
Albania
10
Vietnam
10
USA
9
Laos
9
Tajikistan
9
Guinea-Bissau
8
Jordan
8
Lebanon
8
China
8
Benin
8
Argentina
8
Niger
7
Iraq
7
Georgia
7
Saudi Arabia
6
Togo
6
Peru
6
North Macedonia
6
Chile
6
Paraguay
6
Chad
5
Gambia
5
Papua New Guinea
5
Burundi
5
Sri Lanka
5
Poland
5
Palestine
5
Armenia
5
Timor Leste/ East Timor
5
North America
5
Turkey
4
Egypt
4
Hungary
4
Ecuador
4
Libya
4
Mexico
4
Romania
4
Kazakhstan
4
Japan
4
Spain
4
Honduras
3
El Salvador
3
Bhutan
3
Southern Africa
3
Canada
3
Iran
3
Turkmenistan
3
Tunisia
3
Belarus
3
Morocco
2
Malaysia
2
Mauritania
2
Bolivia
2
Greece
2
Congo-Brazzaville
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Gabon
2
Jamaica
2
France
2
Mauritius
2
Ireland
1
Singapore
1
Serbia
1
Cape Verde
1
Other region
1
North Korea
1
Italy
1
Djibouti
1
Lithuania
1
Uruguay
1
Belgium
1
Maldives
1
United Kingdom
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
2123
Clinical Guidelines
507
Public Health
378
Key Resources
251
Women & Child Health
234
Capacity Building
79
Pharmacy & Technologies
69
Annual Report MEDBOX
2
Toolboxes
COVID-19
639
HIV
478
TB
398
Mental Health
328
Ebola
251
Rapid Response
240
AMR
208
Planetary Health
161
NTDs
159
NCDs
137
Caregiver
128
Conflict
119
Refugee
95
Disability
91
Global Health Education
84
Pharmacy
80
Zika
65
Natural Hazards
51
Health Financing Toolbox
48
Cholera
47
Polio
40
Specific Hazards
24
Social Ethics
7
South Sudan
2
Typhoon
2
Health Financing
2
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.9% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
This interim guidance is for LTCF managers and corresponding infection prevention and ... (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus from entering the facility and spreading within the facility, and 2) to support safe conditions for visiting through the rigorous application of IPC procedures for the residents’ well-being. WHO will update these recommendations as new information becomes available.
Availabel in English, French, Russian and Spanish
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-... sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiopia at least 31.3 billion birr (US$ 1.1 billion) per year, equivalent to 1.8% of the gross domestic product (GDP). Less than 15% of the costs are for health care.
Health Evidence Network synthesis report 72
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public ... issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwide represents in reality only 5 to 10% of actual cases.
This guide is intended for medical and non-medical staff responding to a cholera outbreak. It attempts to provide concrete answers to the questions and problems faced by staff, based on the recommendations of reference organisations, such as WHO and UNICEF, as well as Médecins Sans Frontières’ experience in the field.
It is divided into 8 chapters. Chapter 1, Cholera overview, outlines the epidemiological and clinical features of cholera. Chapter 2, Outbreak investigation, explains the method and stages of a field investigation, from the alert to implementation of initial activities. Chapter 3, Cholera control measures, details measures and tools to prevent and/or control cholera transmission and mortality in populations affected, or at risk of being affected, by an epidemic (curative care, prevention means and health promotion activities). Chapter 4, Strategies for epidemic response, addresses the roll-out strategies of the measures described in Chapter 3 which depend on context (e.g. urban, rural, endemic, non-endemic setting, etc.), resources and particular constraints. Chapter 5, Cholera case management, details the different stages of cholera treatment, from diagnosis through to cure.
Chapter 6, Setting up cholera treatment facilities, focuses on the installation of treatment facilities that vary in size and complexity according to operational requirements (treatment centres and units and oral rehydration points). Chapter 7, Organisation of cholera treatment facilities, describes the organisation of these specialized facilities in terms of human resources, supply, water, hygiene and sanitation, etc. Chapter 8, Monitoring and evaluation, presents the key data to be collected and analysed during an epidemic to facilitate a tailored response and evaluate its quality and effectiveness.
The guide includes various practical tools in the appendices to facilitate activities (e.g. water quality tests, job descriptions, documents, etc.). Moreover, the toolbox also contains additional tools in editable formats (individual patient file, cholera case register, pictograms).
Despite all efforts, it is possible that certain errors may have been overlooked in this guide. Please inform the authors of any errors detected.
To ensure that this guide continues to evolve while remaining adapted to field realities, please send any comments or suggestions.
Fully functioning water, sanitation, hygiene (WASH) and health care waste management services are a critical aspect of infection prevention ... control (IPC) practices, and ensuring patient safety and quality of care. Such services are also essential for creating an environment that supports the dignity and human rights of all care seekers, especially mothers, newborns, children and care providers.
WASH and waste services are also critical for preventing and effectively responding to disease outbreaks. The COVID-19 pandemic has exposed gaps in these basic services (Box 1). These gaps threaten the safety of patients and caregivers, and have environmental consequences, especially as a result of large increases in plastic health care waste. In short, WASH is a critical foundation for improving quality across the health system (1).
Many facilities lack plans and budgets for WASH, which has impacts on IPC. This lack of services, and of systems to improve them, compromises the ability to provide safe and quality care, and places health care providers and those seeking care at substantial risk of infection and loss of dignity. Unhygienic health care facilities without drinking water or functional toilets are also a disincentive to seeking care and undermine staff morale – these factors can have a critical impact on controlling infectious disease outbreaks.
Climate change and its impacts on WASH and health services, gender-specific needs, and equity in service provision and management all require rigorous attention, adaptable tools and regular monitoring.
Accessed: 02.04.2020
The article outlines the prioritized research agenda for the prevention and control of chronic r...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time wh...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hep...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations ... community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.
The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources fo... funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within existing programs of the Federal Ministry of Health (FMOH), Federal Ministry of Agriculture and Rural Development (FMARD) and their agencies or institutes. Certain programs and initiatives already have an AMR element incorporated or could,with little effort,include some additional AMR actions, however much is already being planned and has started with existing federal funding and existing staffing and other resources including development partner support and is being driven by significant political will from the ministries as well as implementation support from the Nigerian Centers for Disease Control as the focal point.
Noma (cancrum oris) is a severe gangrenous disease of the mouth and face. It mostly affects children between the ages of 2 and 6 years living in ex...
The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines ... Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic respiratory illnesses in low-resource healthcare settings. It outlines cost-effective interventions for early diagnosis, treatment, and prevention within primary healthcare, focusing on accessible methods for diabetes management, blood pressure control, dietary and lifestyle guidance, and essential medication use. The guidelines aim to support healthcare professionals in delivering effective NCD care where resources are limited, ultimately improving health outcomes and reducing NCD complications.
The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines ... Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic respiratory illnesses in low-resource healthcare settings. It outlines cost-effective interventions for early diagnosis, treatment, and prevention within primary healthcare, focusing on accessible methods for diabetes management, blood pressure control, dietary and lifestyle guidance, and essential medication use. The guidelines aim to support healthcare professionals in delivering effective NCD care where resources are limited, ultimately improving health outcomes and reducing NCD complications.
Part 3: Use Safe Burial Practices
A handbook for leaders and managers
